- de Leval et al. Genomic profiling for clinical decision making in lymphoid neoplasms. Blood 2022;140:2193
- Duncavage et al. Genomic profiling for clinical decision making in myeloid neoplasms and acute leukemia. Blood 2022;140:2228
- Taylor et al. Diagnosis and classification of hematologic malignancies on the basis of genetics. Blood 2017;130:410
- Marron and Joffe. Ethical considerations in genomic testing for hematologic disorders. Blood 2017;130:460
- Kuo et al. The relative utilities of genome-wide, gene panel, and individual gene sequencing in clinical practice. Blood 2017;130:433
- Scherer et al. High-throughput sequencing for noninvasive disease detection in hematologic malignancies. Blood 2017;130:440
- O’Keefe et al. Copy neutral loss of heterozygosity: a novel chromosomal lesion in myeloid malignancies. Blood 2010; 115:2731
- Podar and Anderson. The pathophysiologic role of VEGF in hematologic malignancies: therapeutic implications. Blood 2005;105:1383
- Saez et al. Splicing factor gene mutations in hematologic malignancies. Blood 2017;129:1260
- Bernatsky et al. Hematologic malignant neoplasms after drug exposure in rheumatoid arthritis. Arch Intern Med 2008;168:378
- Martin-Perez et al. Polycomb proteins in hematologic malignancies. Blood 2010;116:5465
- Tegg et al. Anticipation in familial hematologic malignancies. Blood 2011;117:1308
- Gough et al. NUP98 gene fusions and hematopoietic malignancies: common themes and new biologic insights. Blood 2011;118:6247
- Cottini et al Rescue of Hippo coactivator YAP1 triggers DNA damage–induced apoptosis in hematological cancers. Nat Med 2014;20:599(with editorial)
- Chen et al. Splicing factor mutations in hematologic malignancies. Blood 2021;138:599
- Huang and Figueroa. Epigeneetic deregulation in myeloid malignancies. Blood 2021;138:613
- Sportoletti et al. BCOR gene alterations in hematologic diseases. Blood 2021;138:2455